InsiderTrades

Form 4 for NUVB Nuvation Bio Inc.

Accepted 2026-04-08 16:23:17 ET · period of report 2026-04-06 · accession 0001369453-26-000005 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DMT 2026-04-08 16:23 2026-04-06 NUVB Wentworth Kerry Chief REGULATORY Off M - OptEx $1.91 +200.0K 253.0K +377% +$381.0K
DT 2026-04-08 16:23 2026-04-06 NUVB Wentworth Kerry Chief REGULATORY Off S - Sale+OE $4.52 -200.0K 53.0K -79% -$903.6K
DMT 2026-04-08 16:23 2026-04-06 NUVB Wentworth Kerry Chief REGULATORY Off M - OptEx $0.00 -200.0K 300.0K -40% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2026-04-06 M A 100,000 $1.87 153,000 D — —
2 Common Class A Common Stock 2026-04-06 M A 100,000 $1.94 253,000 D — —
3 Common Class A Common Stock 2026-04-06 S D 200,000 $4.52 53,000 D — — (F1) Shares sold pursuant to a 10b5-1 plan dated December 4, 2025. (F2) Price reported is a weighted-average sales price. The shares were sold at prices ranging from $4.44 to $4.64. The Reporting Person will provide, upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
4 Derivative Stock Option (Right to Buy) 2026-04-06 M D 100,000 $0.00 400,000 D $1.87 · — to 2034-02-27 100,000 Class A Common Stock (F3) Option vests as to 25% on the one year anniversary of 2/29/2024, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date.
5 Derivative Stock Option (Right to Buy) 2026-04-06 M D 100,000 $0.00 300,000 D $1.94 · — to 2033-02-27 100,000 Class A Common Stock (F4) Option vests as to 25% on the one year anniversary of 2/28/2023, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date.